Federal Circuit Revives Lexapro Patent Suit

Law360, New York (April 1, 2008, 12:00 AM EDT) -- An appeals court has revived Caraco Pharmaceutical Laboratories Ltd.'s declaratory judgment suit against Forest Laboratories Inc. over a patent for depression drug Lexapro despite a covenant by Forest not to sue its generics-making rival over the patent.

The U.S. Court of Appeals for the Federal Circuit ruled 2-1 on Tuesday that Caraco could sue Forest over U.S. Patent Number 6,916,941 because a controversy would still exist between the drug manufacturers under the Hatch-Waxman Act if the suit could not go forward.

The court said that a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.